HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Triparanol

Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts.
Also Known As:
MER-29; Metasqualene; MER 29; MER29; Benzeneethanol, 4-chloro-alpha-(4-(2-(diethylamino)ethoxy)phenyl)-alpha-(4-methylphenyl)-
Networked: 65 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Nadesan, Puviindran: 2 articles (01/2006 - 06/2005)
2. Alman, Benjamin A: 2 articles (01/2006 - 06/2005)
3. Hopyan, Sevan: 2 articles (01/2006 - 06/2005)
4. He, Miao: 1 article (08/2012)
5. Zhi, Xiu-Yi: 1 article (08/2012)
6. Zhang, Yi: 1 article (08/2012)
7. Bi, Xinyu: 1 article (08/2012)
8. Han, Xingpeng: 1 article (08/2012)
9. Zhao, Hong: 1 article (08/2012)
10. Zhang, Fang: 1 article (08/2012)

Related Diseases

1. Hypercholesterolemia
2. Neoplasms (Cancer)
3. Prostatic Neoplasms (Prostate Cancer)
4. Melanoma (Melanoma, Malignant)
5. Lung Neoplasms (Lung Cancer)

Related Drugs and Biologics

1. Cholesterol
2. Clomiphene (Clomifene)
3. Ethamoxytriphetol
4. Diethylstilbestrol (Stilbestrol)
5. Carrageenan
6. Triparanol
7. Sterols
8. Niacin (Nicotinic Acid)
9. Lipids
10. Desmosterol

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Aftercare (After-Treatment)